NCT07490132

Endoscopic Retrograde Cholangiopancreatography

Endoscopic Retrograde Cholangiopancreatography Patient Registry

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 100 (estimated)
• Sponsor: Methodist Health System · Academic / Other
• Sex: All
• Age: 15 Years
• Healthy volunteers: Not accepted

Summary

The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.

Detailed description

The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.

Conditions

• Gastro-Intestinal Disorder

Interventions

Type	Name	Description
OTHER	Patients undergoing ERCPs at Methodist Dallas Medical Center	The registry will include all patients who meet registry inclusion. Enrollment will terminate once 25 years of data are captured: January 1, 2000 through December 31, 2025.

Timeline

• Start date: 2026-02-01
• Primary completion: 2027-02-01
• Completion: 2028-02-01
• First posted: 2026-03-24
• Last updated: 2026-03-24

Locations

1 site across 1 country: United States